VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 13 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,800 | +37.6% | 10,000 | 0.0% | 0.01% | +25.0% |
| Q1 2023 | $7,850 | +26.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $6,223 | -43.4% | 10,000 | 0.0% | 0.00% | -42.9% |
| Q3 2022 | $11,000 | -31.2% | 10,000 | 0.0% | 0.01% | -22.2% |
| Q2 2022 | $16,000 | -79.2% | 10,000 | -55.6% | 0.01% | -69.0% |
| Q4 2021 | $77,000 | – | 22,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 988,165 | $614,935 | 0.54% |
| Quantum Private Wealth, LLC | 10,000 | $6,223 | 0.00% |
| Warberg Asset Management LLC | 17,012 | $10,561 | 0.00% |
| Belpointe Asset Management LLC | 19,045 | $11,852 | 0.00% |
| OSAIC HOLDINGS, INC. | 600 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 100,875 | $62,744 | 0.00% |
| WELLS FARGO & COMPANY/MN | 59 | $37 | 0.00% |
| NORTHERN TRUST CORP | 15,221 | $9,472 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 66,038 | $41 | 0.00% |